Patent Assignment
Reel/Frame 065533/0572
License
Recorded: 2023-11-09
Pages: 27
Assignor
ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
Executed: 2021-10-19
Assignee
CYRUS THERAPEUTICS, INC.
5F, KD70 BLDG., 4, JEONGUI-RO-8-GIL, SONGPA-GU, SEOUL, 05836, KOREA, REPUBLIC OF
Covered Properties
(2)
Substituted N-(2-(2,6-Dioxopiperidin-3-Yl)-1,3-Dioxoisoindolin-5-Yl)Arylsulfonamide Analogs as Modulators of Cereblon Protein
Substituted N-(2-(2,6-Dioxopiperidin-3-Yl)-1,3-Dioxoisoindolin-5-Yl)Arylsulfonamide Analogs as Modulators of Cereblon Protein
Application:
63/082,365 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 5, 2021
From: FISHER, MARCUS; KERAMATNIA, FATEMEH; MCGOWAN, KEVIN; MIN, JAEKI
To: ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
Reel/Frame 055164/0729 →
Assignment of Assignor's Interest
Sep 23, 2021
From: MULLIGHAN, CHARLES G.; CHANG, YUNCHAO
To: ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
Reel/Frame 057570/0179 →
Assignment of Assignor's Interest
Sep 14, 2023
From: FISHER, MARCUS; KERAMATNIA, FATEMEH; MCGOWAN, KEVIN; MIN, JAEKI
To: ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
Reel/Frame 064907/0531 →
License
Dec 16, 2025
From: ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
To: CYRUS THERAPEUTICS, INC.
Reel/Frame 073233/0326 →